Fuda Cancer Hospital - Philippines

Home
Philippines
Makati
Fuda Cancer Hospital - Philippines

Fuda is committed to providing cancer patients around the world with the best medical care.

Fuda Cancer Hospital is considered one of the BEST cancer hospitals in China by patients and is affiliated to Jinan University and Translational Medicine Center Fuda Cancer Hospital South District and Fuda Cancer Hospital North District (collectively, “Fuda Cancer Hospital”) are located in Guangzhou, in the south of China. Both hospitals are modern and specialized cancer centers that are recognized for their minimally invasive therapies and innovative treatments that provide an effective alternative to the traditional treatment of chemotherapy/radiation/surgery. Fuda Cancer Hospital is affiliated with the Chinese Academy of Sciences’ Guangzhou Institute of Biomedicine and Health. The hospitals are teaching hospitals of Jinan University School of Medicine. In 2010, the central government designated the hospitals as nationally important clinics and awarded a five million RMB grant to them. The honorary president of the hospital is Academician Mengchao Wu, and the president is Professor Kecheng Xu, a renowned and highly respected specialist of general oncology and gastroenterology. Fuda Cancer Hospital focuses on the diagnosis and treatment of liver, lung, breast, nasopharyngeal, colorectal, uterus, stomach, esophageal, pancreatic, tongue, prostate, skin, larynx, and lymphoma cancers, as well as many others. The hospital insists on providing patient care and services and adopting an individualized approach in the treatment of patients based on their individual conditions. By combining conventional treatment with newly developed technologies and traditional Chinese medicine, the hospital is equipped to treat patients with a complete spectrum of available therapies, from the traditional to the cutting-edge. Besides the conventional treatments for cancer (surgery, chemotherapy and radiotherapy) the hospital has brought together innovative and proven new technologies such as Nano Knife Therapy, Interventional Hepasphere, cryosurgical ablation (CSA), vascular interventional therapy, Cancer Microvessel Intervention (CMI), photodynamic therapy, seed knife brachytherapy, radiofrequency ablation and bioimmunotherapy. The hospital prides itself on using a “3C+P” approach when treating patients: CSA, CMI, combined immunotherapy for cancer (CIC), and personalized therapy. So far, Fuda Cancer Hospital has performed more than 10,000 cases of cryosurgical ablation, and it performs the most number of cryosurgical ablations annually in the world. Dr. Franco Lugnani, the president of the International Society of Cryosurgery, has lauded Fuda for its efforts. Furthermore, the International Society of Cryosurgery designated the hospital as a training center for doctors from the Asian-Pacific region who are interested in cryosurgery. The hospital’s concept and diagnostic techniques have gained a great reputation from countries throughout southeast Asia, as well as the United States, the United Kingdom, Spain, Denmark, Netherlands, and other countries.

27/03/2026

Mar.27.2026.
.
【Minimally Invasive Treatment】【Lung Nodule -Cryoablation】
>>>Cryoablation of Lung Nodule in an 82-Year-Old Veteran> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +63 917 775 3426.
🌟 WhatsApp: +63 917 775 3426.
🌍 Website: https://en.fudahospital.com/

23/03/2026

Mar.23.2026.
.
[Fuda News | International Conference]
Frontiers Converge: President Niu LizhiAttends the 2026 IO&E PhysicianAdvisory Board Meeting
From March 13 to 14, the 2026 International Oncology & Embolization Physician Advisory Board Meeting (2026 IO&E SAB) was held in Minnesota, USA. The meeting brought together 24 leading experts from around the world to explore cutting-edge technologies and jointly shape the future of the field.
7E89780F-019E-43E1-824B-27676967CF5B.png
C1601450-82F3-4967-835C-E02B3AAB5265.jpg
In recognition of his profound expertise in minimally invasive cancer therapies and his strong international reputation, President NiuLizhi of Guangzhou Fuda Cancer Hospital was invited to attend as one of five representatives from Asia. During the meeting, he engaged in in-depth discussions and academic exchanges with top scholars from the United States, Europe, and across Asia, focusing on the latest advancements in interventional oncology and tumor ablation. He also shared valuable insights drawn from China’s clinical experience, combining practical expertise with innovative thinking.
E10471F9-6538-4DC6-BA4A-ED1F6340740A.jpg
△ President Niu Lizhi with Professor Matthew from Mayo Clinic, recalling their interaction and photo at the WCIO conference 10 years ago

01B334D7-D228-49CB-B0F1-0D22D4E751C2.jpg

△ President Niu Lizhi with Professor Koichiro Yamakado, President of the Japan Radiological Society

B61DFFB0-8245-4135-BFD3-5BF2690D3820.jpg

△ President Niu Lizhi discussing the development of cryoablation technology with a technical expert from Boston Scientific

Academic progress knows no borders, and collaboration drives innovation. This SAB meeting was not only a platform for exchanging cutting-edge knowledge, but also an opportunity to deepen international cooperation. President Niu’s participation reflects the growing global recognition of China’s advancements in minimally invasive cancer treatment. Through this platform, a strong and confident “China voice” was shared with the world, highlighting the capabilities of Chinese medical institutions in the field of interventional oncology and ablation.
9EB57E0D-6B29-40CB-88A5-BB3E7BFB46EE.jpg
“Through in-depth exchanges with leading experts worldwide, we have gained a more comprehensive understanding of the latest developments and future trends in cancer diagnosis and treatment,” said President Niu. “We will integrate these cutting-edge insights into our clinical practice, striving to provide more advanced technologies and higher-quality care to better safeguard the lives and health of every cancer patient.”

Click to learn more patient stories:
>>> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +63 917 775 3426.
🌟 WhatsApp: +63 917 775 3426.
🌍 Website: https://en.fudahospital.com/

23/03/2026

Mar.22.2026.
.
【patient’s story】【China- cervical cancer- interventional chemotherapy】
From “Deserter” to “Returning to the Front”: A 15-Year Journey of a Cervical Cancer Patient
On the long road of fighting cancer, Ms. Li (pseudonym) admits that she was once a disobedient “deserter.” Yet somehow, this “deserter” was pulled back to the battlefield again and again—by her family, by her doctors, and by the small but persistent will to live that never truly faded.
Her story began 15 years ago.
Ms. Li comes from the grasslands of Inner Mongolia. That year, she went to a local hospital because of vaginal dryness and pain. The diagnosis—“cervical cancer”—hit her life like a bullet.
C6BA219D-4F80-4A00-BF5B-549418EF4758.jpg
In fact, there had been warning signs. Back in 2009, she had experienced contact bleeding, but she did not take it seriously.
Radical surgery for cervical cancer, radiotherapy, chemotherapy… After a round of intensive treatments, she endured it all. The cancer cells actually retreated. For more than seven years, her follow-up reports were mostly clear. This meant she had passed the “five-year safety period,” which usually indicates a high chance of long-term survival.
Ms. Li thought so too.
Gradually, she let her guard down. Smoking, drinking, playing mahjong—in the smoke-filled card rooms, she felt no different from anyone else. Life, she believed, should be lived with warmth and vitality.
What she did not know was that cancer cells often strike when vigilance fades.
It was in 2017 when Ms. Li caught a cold and developed a persistent cough that would not go away. Her family felt something was wrong and urged her to see a doctor. The doctor studied her scans for a long time. After learning about her history of cervical cancer, he advised her to go to a larger hospital for further examination.
“The doctor said there were many shadows in my lungs—maybe seven or eight,” she recalled.
She traveled to Harbin and Tianjin, visiting hospitals in two cities. Both gave the same diagnosis: lung metastases from cervical squamous cell carcinoma.
At that moment, Ms. Li broke down in tears. She thought the battle had long been over. She thought seven years without problems meant a lifetime without problems. She thought… but the cancer cells thought otherwise.
The next three years were painful. Systemic chemotherapy brought nausea, vomiting, hair loss, and fatigue—none of it spared her. Even worse, while enduring the suffering, she watched the nodules on her follow-up scans grow larger and more numerous.
Eventually, drug resistance developed, and the cough became uncontrollable. Ms. Li herself felt that enduring day after day was almost like waiting for death.
But her daughter refused to give up. She believed that in such a big world, there had to be a better solution.
Through a friend in Changchun, she learned about a treatment called cryoablation. That friend had once traveled to Japan for the same treatment but was not satisfied with the results. After returning to China, he found President Dr. Niu Lizhi at Fuda Cancer Hospital in Guangzhou, underwent cryoablation again, and finally achieved a satisfactory outcome.
Hearing this, Ms. Li’s daughter felt a spark of hope—like seeing a faint light in the darkness.
In October 2021, Ms. Li traveled south to Guangzhou and arrived at Fuda. But deep inside, she was anxious. Her condition seemed so serious—could it still be treated?
“Multiple metastatic tumors in both lungs, close to the right lower pulmonary artery, adhesions with the interlobar pleura and chest wall pleura…”
Based on her condition, the medical team performed two sessions of cryoablation for lung metastases, along with needle biopsies. The biopsy results once again confirmed: metastases from the original cervical cancer.
After the procedures, Ms. Li continued with chemotherapy and immunotherapy. For more than a year afterward, her disease remained stable.
But once things stabilized, Ms. Li’s thoughts began to wander again.
“If it’s stable, isn’t that good enough? Maybe I don’t need further treatment.”
Then in January 2024, the tumors grew again.
Ms. Li returned to Fuda and underwent a third cryoablation procedure. However, there were too many nodules, and some continued to enlarge. She subsequently received three iodine-125 seed implantations, which finally reduced the tumors.
Just as her attending doctor suggested consolidating the treatment with interventional chemotherapy, Ms. Li’s “escape plan” resurfaced once more.
DDE6E28A-34C5-4B87-967A-5F6DB1AA616A.png B61E5D6A-2B63-4E44-B0BF-913041D5CA7E.pngF65BF4AD-A12B-4228-ABB9-E47A25F39674.png BD822CFF-B050-4EE3-8532-D8D4AFED35AC.png29783142-AC22-4CE7-BA88-59FD45A08580.png F861CA0B-8F79-45C4-AA10-0673D27A52BF.png
“I had seen other patients undergo interventional therapy before—the reactions looked severe… I was scared,” she said. This time, she truly wanted to give up. After so many cycles of treatment and recurrence, she was exhausted.
Then one day, Ms. Li received a call from her attending physician, Dr. Yang Ting.
The voice on the other end was as gentle and calm as always:
“Ms. Li, it’s time for your treatment. Please come back.”
Just that single sentence left her stunned for a long time.
Her family continued persuading her. At that moment, she thought about her young child and about how many patients in their seventies and eighties were still fighting. Why shouldn’t she keep going?
The interventional treatment turned out to be far less frightening than she had imagined—and the results surprised her.
The lung metastases shrank. The lymph nodes also shrank. Even the cough that had troubled her for years almost disappeared.
“Director Zhong Xiaojun from the interventional department knew I was very scared, so he chatted with me the whole time. Before I even realized it, the procedure was already done,” she said.
Fifteen years have passed. For Ms. Li, it feels like fighting three battles.
In the first battle, she won—and became careless.
In the second battle, she lost—and nearly gave up.
In the third battle, she is still fighting.
She once ran away from the battlefield, a “deserter” in her own words. But time and again, she was pulled back.
And this time, she finally sees the dawn of victory.
Click to learn more patient stories:
>>> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +63 917 775 3426.
🌟 WhatsApp: +63 917 775 3426.
🌍 Website: https://en.fudahospital.com/

18/03/2026

MAR.18.2026.
.
【Paitent’s Story】【Hong Kong - Tongue Cancer - Interventional Chemotherapy+ Brachytherapy】
>>>From Desperation to Recovery: A Hong Kong Patient’s Fight Against Tongue Cancer> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +63 917 775 3426.
🌟 WhatsApp: +63 917 775 3426.
🌍 Website: https://en.fudahospital.com/

03/03/2026

Mar.3.2026.
.
【Minimally Invasive Treatment】【Cholangiocarcinoma-NanoKnife】
>>>Recurrent Cholangiocarcinoma: NanoKnife Brings Hope to Hepatic Hilum> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +63 917 775 3426.
🌟 WhatsApp: +63 917 775 3426.
🌍 Website: https://en.fudahospital.com/

26/02/2026

Feb.26.2026.
.
[Fuda News] [Free Medical Outreach]
Heartwarming New Year’s Gift: Fuda Free Medical Outreach Brings Warmth to the Community
As the Lunar New Year approaches, warmth arrives ahead of the festivities. Staying true to the original mission of medical professionals and committed to safeguarding community health, the Outpatient Department of Guangzhou FudaCancer Hospital recently partnered with neighboring communities to launch a series of free medical outreach events—delivering convenient, high-quality healthcare services along with heartfelt New Year blessings right to residents’ doorsteps.
From Tangde South Community, to Tianhe District Elderly Home, and onward to JianghaiSubdistrict, the outreach footprint continued to expand—truly realizing the goal of “fewer trips for residents, health services delivered by experts.” The atmosphere at each event was warm and lively, with a steady stream of residents seeking consultations. Medical staff from departments including Internal Medicine, Traditional Chinese Medicine, and Oncology patiently provided blood pressure and blood glucose checks, offered traditional Chinese cupping therapy experiences, and delivered practical, easy-to-understand health education. Topics covered included chronic disease management for hypertension and diabetes, rehabilitation for post-stroke complications, monitoring of pulmonary nodules, and cancer prevention and treatment.
E2EAF922-D7D1-4942-9F0B-625EEC789E65.png96782D19-4488-43B8-AC2A-FDB805D91E14.png5CB3633F-BC23-4EB6-97B6-C2ACFA67B271.png36079729-B4A2-4395-B7EF-B2F34AABA470.png
At Tianhe District Elderly Home, a special New Year-themed dietary health lecture titled “Healthy Silver Years, Welcoming the Spring Festival” was warmly received. Ning Xueming, Head Nurse of Tianhe Outpatient Clinic, alternated between Cantonese and Mandarin to explain in a friendly and accessible manner the principles of festive dining—“warm, soft, and easy-to-digest foods; smaller, more frequent meals; and a balanced mix of meat and vegetables.” Head Nurse Liu Ping led interactive games that filled the room with laughter. When the conversation turned to classic Guangdong New Year’s Eve dishes, the elderly participants eagerly shared their own family “New Year flavors.” One gentleman joked, “You’re making my mouth water just listening!” Behind the laughter was unmistakable warmth, and in that moment, the distance between hearts quietly disappeared.
A13C04C8-FDB1-4537-AF8C-F56D1A47FB16.jpg
In the year ahead, our hospital will continue to uphold the original mission of medical professionals and actively fulfill its social responsibilities. Through regular free clinics, charitable medical services, and public health education programs, we will bring warmer, higher-quality healthcare services closer to the people, contributing further to the high-quality development of healthcare services.
2652173B-4924-4770-8D0E-E7FF1CF285B2.png
0EDAD0A9-A6BF-40C1-9836-955BD3383D83.png
May health and warmth always be by your side.
We wish you and your family:
Good health, abundant blessings, and success in all things!
Click to learn more patient stories:
>>> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +63 917 775 3426.
🌟 WhatsApp: +63 917 775 3426.
🌍 Website: https://en.fudahospital.com/

14/02/2026

FEB.14.2026.
.
“Happy Hearts Day”…

12/02/2026

Feb.12.2026.
.
[Patient Story]
[Antigua and Barbuda – Oropharyngeal Squamous Cell Carcinoma – Arterial Infusion Chemotherapy]

Simple Sore Throat Turned Out to Be Oropharyngeal Cancer：Foreign Patient Refuses Surgery and Travels Across Borders in Search of a “China Solution”
What began as a mild discomfort in the throat gradually worsened—until Robert (pseudonym) could no longer open his mouth properly, speak clearly, or even brush his teeth. Drinking water became difficult. His hearing deteriorated, headaches became frequent, and even the shape of his face slowly changed.
All of this started from what seemed like an “insignificant” throat discomfort.
Robert was born in Antigua and Barbuda, a small island nation in the Caribbean. Toward the end of 2024, he began to feel discomfort on the right side of his throat. At first, he paid little attention. However, the symptoms continued to worsen. By March 2025, he noticed a mass in his oropharynx, yet still delayed seeking medical care.
Two months later, lumps appeared on both sides of his neck, and hearing loss in his right ear became obvious. Only then did he realize the seriousness of the situation and underwent examinations at a hospital in the Philippines.
The diagnosis was devastating: oropharyngeal squamous cell carcinoma. By October 2025, the disease had already progressed.
At that time, Robert was suffering from nasal obstruction on the right side, hearing impairment, difficulty swallowing, swelling and pain in his cheek and throat, and occasional bleeding from the oropharyngeal mass. Everyday life had become a constant ordeal.
Health Insight
The oropharynx, hidden behind the oral cavity, acts as a vital crossroads for breathing, swallowing, and speech. When cancer develops in this area, early symptoms are often subtle and easily overlooked—such as persistent sore throat, a sensation of a foreign body when swallowing, or changes in voice.
5C1F24DC-2827-464B-B056-F978574F82BE.jpg
Image source: Internet
Seek medical attention promptly if you experience:
• Persistent foreign-body sensation in the oropharynx, especially worsening during swallowing (unlike pharyngitis, which may improve while eating);
• Continuous throat pain affecting daily life;
• Oral ulcers that do not heal, or unexplained bleeding in the mouth;
• Painless neck lumps (enlarged lymph nodes) unresponsive to anti-inflammatory treatment;
• Difficulty opening the mouth or breathing (late-stage symptoms).
If any of these symptoms persist, timely medical evaluation is strongly recommended.
Local doctors advised radical surgery, but the potential extensive trauma led Robert to refuse it. In his mind, surgery was a last resort.
“There must be a more advanced and gentler option,” he believed.
Through social media, Robert learned about Guangzhou Fuda Cancer Hospital in China and its specialized minimally invasive treatment approaches. With a hopeful mindset, he contacted Fuda’s service center in the Philippines and completed an online consultation. When he learned that multiple treatment options were still available to him, he made a decisive choice—to travel to China.
At Fuda, comprehensive examinations revealed that the tumor had invaded the nasopharynx, soft palate, and right-sided muscles, with a high risk of bleeding. Instead of traditional open surgery, the medical team designed a personalized combination treatment plan:
• Arterial infusion chemotherapy to deliver drugs directly to the tumor with high precision;
• Interventional embolization to block blood vessels and reduce bleeding risk;
• Combined with intravenous PD-1 inhibitor immunotherapy, reactivating the immune system to recognize and attack cancer cells.
The results exceeded Robert’s expectations.
Before long, his right nasal passage became clear, his hearing improved, and the neck masses visibly shrank. Swallowing was no longer difficult, and he could finally eat and sleep comfortably again. Although his voice remained slightly hoarse, his laughter was loud and genuine.
ED3ED40C-A9D3-4049-BB02-BEAD8379B8D3.png
176202D7-9F20-495A-8C26-C6CB37319ADB.png
CT comparison after two treatment cycles showing reduction of oropharyngeal tumor and cervical masses
Robert shared that he had visited China more than a decade ago, but this was his first time coming to Guangzhou as a patient. At the beginning, anxiety kept his blood pressure elevated. Yet the hospital’s professional expertise and warm, attentive care quickly put him at ease.
This experience made him truly fall in love with China. He said that he hopes to seriously learn Chinese in the future, explore the country’s culture, and fully experience its unique charm.
Robert’s treatment is still ongoing. We sincerely wish him steady progress toward recovery—and a return to a life filled with sound, freedom, and color.

Click to learn more patient stories:
>>> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +63 917 775 3426.
🌟 WhatsApp: +63 917 775 3426.
🌍 Website: https://en.fudahospital.com/

05/02/2026

FEB.5.2026.
.
【Pancreatic Cancer】【Cryoablation Nanoknife】
>>>New Option for Pancreatic Cancer> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +63 917 775 3426.
🌟 WhatsApp: +63 917 775 3426.
🌍 Website: https://en.fudahospital.com/

Address

Unit 2522, 25th Floor, Centuria Medical Makati Building
Makati
1210

Telephone

+639177753426

Website

http://phl.fudahospital.com/

Alerts

Be the first to know and let us send you an email when Fuda Cancer Hospital - Philippines posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Want your practice to be the top-listed Clinic in Makati?

Our Story

Fuda Cancer Hospital South District and Fuda Cancer Hospital North District (collectively, “Fuda Cancer Hospital”) are located in Guangzhou, in the south of China. Both hospitals are modern and specialized cancer centers that are recognized for their minimally invasive therapies and innovative treatments that provide an effective alternative to the traditional treatment of chemotherapy/radiation/surgery. Fuda Cancer Hospital is affiliated with the Chinese Academy of Sciences’ Guangzhou Institute of Biomedicine and Health. The hospitals are teaching hospitals of Jinan University School of Medicine. In 2010, the central government designated the hospitals as nationally important clinics and awarded a five million RMB grant to them. The honorary president of the hospital is Academician Mengchao Wu, and the president is Professor Kecheng Xu, a renowned and highly respected specialist of general oncology and gastroenterology. Fuda Cancer Hospital focuses on the diagnosis and treatment of liver, lung, breast, nasopharyngeal, colorectal, uterus, stomach, esophageal, pancreatic, tongue, prostate, skin, larynx, and lymphoma cancers, as well as many others. The hospital insists on providing patient care and services and adopting an individualized approach in the treatment of patients based on their individual conditions. By combining conventional treatment with newly developed technologies and traditional Chinese medicine, the hospital is equipped to treat patients with a complete spectrum of available therapies, from the traditional to the cutting-edge. Besides the conventional treatments for cancer (surgery, chemotherapy and radiotherapy) the hospital has brought together innovative and proven new technologies such as Nano Knife Therapy, Interventional Hepasphere, cryosurgical ablation (CSA), vascular interventional therapy, Cancer Microvessel Intervention (CMI), photodynamic therapy, seed knife brachytherapy, radiofrequency ablation and bioimmunotherapy. The hospital prides itself on using a “3C+P” approach when treating patients: CSA, CMI, combined immunotherapy for cancer (CIC), and personalized therapy. So far, Fuda Cancer Hospital has performed more than 12,000 cases of cryosurgical ablation, and it performs the most number of cryosurgical ablations annually in the world. Dr. Franco Lugnani, the president of the International Society of Cryosurgery, has lauded Fuda for its efforts. Furthermore, the International Society of Cryosurgery designated the hospital as a training center for doctors from the Asian-Pacific region who are interested in cryosurgery. The hospital’s concept and diagnostic techniques have gained a great reputation from countries throughout southeast Asia, as well as the United States, the United Kingdom, Spain, Denmark, Netherlands, and other countries. Fuda is also a Joint Commission International (JCI) accredited, JCI is from the USA that monitors all private and government hospitals in the world to follow the international standard patient and treatment safety protocols. Fuda Makati Satellite office offers second opinion consultation to review and provide other treatment options besides the traditional surgery, chemotherapy and radiotherapy. To know more about our services and capabilities please go through of our page and then contact us. Thank you and Mabuhay!!!

Fuda Cancer Hospital - Philippines

27/03/2026

23/03/2026

23/03/2026

18/03/2026

03/03/2026

26/02/2026

14/02/2026

12/02/2026

05/02/2026

Address

Telephone

Website

Alerts

Shortcuts

Share

Category

Our Story